Search Results 501-510 of 17374 for Safe STD Testing

1. Azathioprine (oral route) - Side effects & dosage - Mayo Clinic

   Safety and efficacy have not been established. Geriatric. No information is available on the relationship of age to the effects of azathioprine in geriatric ...

2. Mpox (monkeypox): What is it and how can it be prevented? - Mayo Clinic

   Find out more about this rare viral infection, the possible symptoms in humans, treatment options and how to prevent getting or spreading the virus.

3. A Study of the Safety and Effectiveness of the Mentor Larger Size MemoryGel Ultra High Profile Breast Implants in Subjects who are Undergoing Primary Breast Reconstruction or Revision Reconstruction - Mayo Clinic

   The purpose of this study is to evaluate the safety and effectiveness of the Mentor MemoryGel® larger size ultra high profile breast implants for patients who ...

4. Halloween safety tips during COVID-19 - Mayo Clinic News Network

   Traditionally, many children of all ages go door to door trick-or-treating on Halloween. This year, the recommendation is to avoid that activity and ...

5. Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors - Mayo Clinic

   The purpose of this research is to see how well fruquintinib works in combination with tislelizumab in participants with metastatic colorectal cancer (mCRC).

6. Metronidazole (vaginal route) - Side effects & dosage - Mayo Clinic

   Safety and efficacy have not been established. Geriatric. Appropriate studies performed to date have not demonstrated geriatric-specific problems that would ...

7. A Study to Compare the Effectiveness, Safety and Tolerability of P1101 vs. Anagrelide for Essential Thrombocythemia - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

8. A Study to Evaluate the Effectiveness and Safety of MEDI2070 in Subjects with Active Moderate to Severe Crohn's Disease - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

9. A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL) - Mayo Clinic

   A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin ...

10. A Study To Assess The Efficacy And Safety Of Efgartigimod IV In Adult Participants With Primary Immune Thrombocytopenia - Mayo Clinic

    ... safety of efgartigimod IV in participants with primary immune thrombocytopenia (ITP). After an up to 2 weeks screening period, eligible participants will be ...